Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06223607
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
Sponsor: Methodist Health System
View on ClinicalTrials.gov
Summary
The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2022-08-22
Completion Date
2027-12-22
Last Updated
2026-06-10
Healthy Volunteers
No
Conditions
Locations (1)
Methodist Dallas Medical Center
Dallas, Texas, United States